Efficiency validation for application of medical and psychological rehabilitation and digitalpsychophysiological therapy in regulation of atherosclerosis development at the level of neuropeptide-cytokine links of immune system in polymorbid cardiovascular pathology in presence of affective spectrum disorders in marine specialists in the Far North

Scientific medical literature has accumulated a lot of data suggesting most important components of coronary heart disease pathogenesis and hypertension to be complex triggering processes of neuro-immune and neuro-endocrine interactions. Risk factors for cardiovascular diseases at the initial stages of atherosclerosis formation cause endothelial dysfunction and trigger a cascade of immune inflammation in coronary vessels, which is based on shifting immune response towards activation of lymphocytes, with predominance of cellular immune reactions. As a rule, it results in remodeling of the vascular wall under participation of proinflammatory cytokines, shifting blood lipid balance towards atherogenicity, destabilization of atherosclerotic plaque, development of thrombosis and acute coronary syndrome. In this respect, the aim of our work was to develop treatment methods that allow, under participation of endogenous immune regulators, to change the structure of pro-atherogenic links via their interactions at the initial stages of the atherosclerotic lesion formation in chronic coronary heart disease and hypertension.

To achieve this goal, 80 patients (men) were selected among the marine specialists of the ship crews serving in the Arctic latitudes and the Far North, with ischemic heart disease, stage 1 hypertension and astheno-neurotic disorders with anxiety and depressive manifestations. The groups of patients were formed as follows: Group 1 (n = 31, patients who received standard therapy with cardiotropic drugs; Group 2 (n = 29), subjects who underwent drug correction with weak tranquilizers as a part of standard cardiotropic therapy; Group 3 (n = 34), standard therapy accompanied by medical and psychological rehabilitation and digital psychophysiological therapy. Effectiveness of the treatment was studied by assessing the dynamics of parameters characterizing the neuropeptide-cytokine immune status, the markers used in the diagnostics of atherosclerosis, as well as paired relationships between them. The laboratory part of the work was represented by a set of diagnostic kits, including markers of atherosclerotic process, and test systems for determination of β-endorphin, proinflammatory cytokines (TNF α, IL-1 β, IL-6), and anti-inflammatory (IL-4, IL-10) spectrum.

We have found that the use of medical and psychological rehabilitation, along with digital psychophysiological therapy contributes to optimization of neuropeptide-cytokine interactions, thus showing efficiency of cardiotropic drugs usage. It seems to correct the relationships within proatherogenic structures of immune system and pathogenetic links involved in development of atherosclerotic process in polymorbid cardiovascular pathology from marine specialists with intense workloads.

1. Alekseeva G.V. Oxidant activity of leukocytes and proinflammatory cytokines in acute coronary syndrome. Arterialnaya gipertenziya = Arterial Hypertension, 2008, Vol. 14, no. 2, Suppl. 2, pp. 68-72. (In Russ.)

2. Gein S.V., Baeva T.A. The role of opioid peptides in the regulation of lymphocyte proliferation and changes in the Th1/Th2 cytokine profile. Problemy endokrinologii = Problems of Endocrinology, 2005, no. 5, pp. 49-51. (In Russ.)

3. Gein S.V., Baeva T.A., Kichanova O.A. Effect of P-endorphin on antibody genesis and IL-4 production under opiate receptor blockade. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2006, Vol. 142, no. 8, pp. 192-195. (In Russ.)

4. Gein S.V, Gorshkova K.G., Tendryakova S.P. The role of beta-endorphin in the regulation of proinflammatory cytokine production by peripheral blood monocytes in vitro. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2007, no. 2, pp. 175-178. (In Russ.)

5. Gurin A.V, Molosh A.I., Sidorenko G.I. Intermittent ischemia is a unique adaptive phenomenon. The prospect of new ways of pharmacological action. Kardiologiya = Cardiology, 1997, no. 6, pp. 45-52. (In Russ.)

6. Zakirova N.E., Khafizov N.Kh., Karamova I.M., Zakirova A.N., Oganov R.G. Immuno-inflammatory reactions in ischemic heart disease. Ratsionalnaya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology, 2007, Vol. 3, no. 2, pp. 16-19. (In Russ.)

7. Koryakina L.B., Pivovarov Yu.I., Kurilskaya T.E., Sergeeva A.S., Babushkina I.V. Vascular endothelial dysfunction in arterial hypertension and coronary heart disease. Byulleten vostochno-sibirskogo nauchnogo tsentra sibirskogo otdeleniya rossiyskoy akademii meditsinskikh nauk = Bulletin of the East Siberian Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences, 2013, Vol. 90, no. 2-1, pp. 165-170. (In Russ.)

8. Lishmanov Yu.B., Tsibulnikov S.Yu., Naryzhnaya N.V., Korobov M.V., Maslov L.N. The role of the endogenous opioid system in the regulation of heart tolerance to stress damage. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2017, Vol. 163, no. 1, pp. 32-35. (In Russ.)

9. Lishmanov Yu.B., Maslov L.N. Opioid neuropeptides, stress and adaptive protection of the heart. Tomsk: Tomsk University Press, 1994. 352 p.

10. Lozovaya T.A. Cytokine activity and functional state of the myocardium in patients with paroxysms of atrial fibrillation in ischemic heart disease. Visnyk Sumskoho derzhavnoho universytetu = Bulletin of Sumy State University, 2006, Vol. 92, no. 8, pp. 140-146. (In Russ.)

11. Lutai M.I. Atherosclerosis: a modern view of pathogenesis. Ukrainskiy kardiologicheskiy zhurnal = Ukrainian Cardiological Journal, 2004, no. 1, pp. 12-16. (In Russ.)

12. Lutai M.I., Golikova I.P., Deyak S.I. Systemic inflammation in patients with CHD: the relationship with the clinical course and the presence of risk factors. Ukrainskiy kardiologicheskiy zhurnal = Ukrainian Medical Journal, 2006, Vol. 52, no. 2, pp. 80-83. (In Russ.)

13. Maslov L.N., Lishmanov Yu.B. Changes in the level of opioid peptides in the heart and blood plasma in acute myocardial ischemia complicated by ventricular fibrillation. Voprosy meditsinskoy khimii = Problems of Medical Chemistry, 1992, Vol. 38, no. 2, pp. 21-23. (In Russ.)

14. Ovanesyan R.A., Ovanesyan I.G., Mezhlumyan R.G. Correlations between interleukin IL-1P and the degree of platelet aggregation in ischemic stroke. Gemoreologiya i mikrotsirkulyatsiya = Hemorheology and Microcirculation, 2007, p. 117. (In Russ.)

15. Orlova N.V. Genetic conditionality of inflammation in atherosclerotic lesions of the heart vessels. Serdechnaya nedostatochnost = Heart Failure, 2008, Vol. 9, no. 4, pp. 180-183. (In Russ.)

16. Sergeeva E.G. Proinflammatory cytokines in patients with ischemic heart disease depending on the degree of atherosclerosis prevalence and their dynamics during medostatin therapy. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya = Regional Blood Circulation and Microcirculation, 2002, Vol. 1, no. 4, pp. 40-43. (In Russ.)

17. Serik S.A. Immuno-inflammatory activity in ischemic heart disease. Ukrainskiy kardiologicheskiy zhurnal = Ukrainian Journal of Cardiology, 2002, no. 1, pp. 40-45. (In Russ.)

18. Khavka N.N., Chukaeva I.I., Orlova N.V. Determination of cytokine and protein activity in acute inflammation in patients with arterial hypertension and carbon metal disorders. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention, 2008, Vol. 7, no 6, pp. 388-389. (In Russ.)

19. Chukaeva I.I., Orlova N.V, Evdokimov F.A., Aleshkin V.A., Soloshenkova O.O., Novikova L.I., Rechnova N.P. Inflammation role and antiinflammatory strategies in acute cardiovascular pathology. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology, 2009, Vol. 79, no 5, pp. 30-34. (In Russ.)

20. Bobryshev Y.V., Ivanova E.A., Chistiakov D.A., Nikiforov N.G., Orekhov A.N. Macrophages and their role in atherosclerosis: pathophysiology and transcriptome analysis. BioMed Res. Int., 2016, pp. 1-13.

21. Ettinger W.H., Varna V.K., Sorci-Thoma M. Cytokines decrease apolipoprotein accumulation in medium from Hep.G2 cells. Arterioscler. Thromb., 1994, Vol. 14, no. 1, pp. 8-13.

22. Falcone C., Guasti L., Ochan M., Codega S., Tortorici M., Angoli L., Bergamaschi R., Montemartini C. Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia. J. Am. Coll. Cardiol, 2004, Vol. 22, no. 6, pp. 1614-1620.

23. Fontana F., Bernardi P, Spampinato S., Toro R., Bugiardini R. P-endorphin modulation of pressor response to hyperventilation in hypertensive patients. Peptides, 2002, Vol. 23, no. 5, pp. 911-918.

24. Hardardottir I., Moser A.H., Memon R., Grunfeld C., Feingold K. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res., 1994, Vol. 13, no. 3, pp. 161-166.

25. Hasdai D., Scheinowitz M., Leibovitz E., Sclarovsky S., Eldar M., Barak V Increased serum concentration of interleukin-1beta in patients with coronary artery disease. Heart, 1996, Vol. 76, no. 1, pp. 24-28.

26. Hojo Y., Ikeda U., Takahashi M., Kazuyuki S. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis, 2002, Vol. 161, no. 2, pp. 403-408.

27. Maslov L., Lishmanov Y. Changes in opioid peptide level in the heart and blood plasma during acute myocardial ischaemia complicated by ventricular fibrillation. Clin. Exp. Pharmacol. Physiol., 1995, Vol. 22, pp. 812-816.

28. Oldroyd K., Gray C., Carter R. Activation and inhibition of the endogenous opioid system in human heart failure. Br. Heart J., 1995, Vol. 73, pp. 41-48.

29. Stefano G., Goumon Y., Bilfinger T., Welters I., Cadet P Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Progress in Neurobiol., 2000, no. 60, pp. 531-544.